Skip to main content

United Therapeutics sues FDA, HHS to get orphan drug designation for Orenitram – Washington Business Journal

By August 11, 2017News
united-therapeutics-logo

united-therapeutics-logo

The company alleges the U.S. Food and Drug Administration isn’t honoring a drug designation program Congress passed in 1983.

{iframe}https://www.bizjournals.com/washington/news/2017/08/07/one-of-md-s-biggest-biotechs-sues-the-feds-to.html{/iframe}

Leave a Reply

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.